SAIPARENT

Sai Parenterals Limited

Pharmaceuticals

A diversified pharmaceutical formulations company, Sai Parenteral's specializes in the research, development, and manufacturing of injectable and parenteral drugs for multiple therapeutic areas. Incorporated in 2001, the company maintains expertise in complex formulation technologies and operates integrated manufacturing facilities. It serves both domestic and international markets, with a focus on quality compliance and advanced pharmaceutical solutions across its product portfolio.

Investors holding Sai Parenterals Limited

Quant Mutual Fund

Mutual Fund

3.81%

Kotak Mahindra Life Insurance

Institution

2.35%

Morgan Stanley

Foreign Investor

1.17%

AC

Astorne Capital

Foreign Investor

1.15%

Latest move